A New Generation of Medicine

Danny graduated from the University of Victoria with a degree in chemistry before becoming an early employee at Aurora Cannabis. His career with Aurora provided foundational experience in enterprise management, good manufacturing practices, and the Controlled Drugs and Substances Act.

Dr. van der Heyden’s scientific focus is on cGMP manufacture of lysergamides, tryptamines and phenethylamines for use in clinical trials, and on biotechnological approaches to assembling precursors and psychedelic drug molecules.

Mr. Mesburis joined Psygen as Chief Financial Officer in 2021. He has more than twenty-five years of international experience in financial and capital markets. He has over a decade of valuable experience as a public company board member of both TSX and TSXV listed companies and expertise in finance, risk management, strategy and governance through his service on board committees. His capital markets experience encompasses senior roles for both buy-side and sell-side firms. On the buy-side, he has managed portfolios for global investment strategies in both debt and equities. On the sell-side, his experience includes senior roles in mergers and acquisitions, investment banking, and institutional equity research at both global and domestic investment banks. In 2012, he was honoured with a Canadian Lipper Fund Award which recognizes funds that have excelled in delivering consistently strong risk-adjusted performance, relative to their peers. He received his Master of Business Administration degree from the Schulich School of Business at York University, his Bachelor of Arts degree from the University of Toronto, and has completed Executive Education at Harvard Business School. Mr. Mesburis holds the Chartered Professional Accountant (Ontario), Chartered Accountant (Ontario), Certified Public Accountant (Illinois), and Chartered Financial Analyst designations. Since 2016, Mr. Mesburis has been a member of the Board of Directors and Audit Committee Chair of Avivagen Inc. (TSXV: VIV).

• Developed and implemented Psygen’s administration and sales programs.
• 6 years education in critical care and aviation retrieval medicine.
• 17+ years Advanced Life Support/Critical Care Paramedic.
• 3 years Assistant Medical Director for HERO Client Rescue, Port Au Prince, Haiti.
• Previous social media manager for BC flight paramedics.
• Entrepreneurial development and manager for a small company with 8 employees.
• Extensive experience in creative leadership and client care.

Bri graduated from the University of Calgary with a BSc in biochemistry and a PhD in physical chemistry. Her R&D experience is diverse with focuses on biomedical device development, petroleum and chemical engineering, agricultural chemical formulation and clean energy process development. Bri’s comprehensive technical, business and research background provide her with the fundamental experience to efficiently and effectively operate the state-of-the-art Psygen laboratory facilities.

Mark Haden is Adjunct Professor of the UBC School of Population and Public Health. He is currently involved with the British Columbia Health Officers Council drug policy committee and provides public information on drugs and drug policy.